Hodgkin Lymphoma Prognosis, Biology Tracked With Circulating Tumor DNA Dec. 11, 2023 — Circulating tumor DNA predicts recurrence and splits disease into two subgroups of Hodgkin lymphoma.

IFRT only needs to be considered for PET-negative patients at high risk of recurrence, according to John Radford, MD.

What exactly causes IVLBCL is unknown ... an aggressive non-Hodgkin’s lymphoma. It’s characterized by the accumulation of lymphoma cells in small- and medium-sized blood vessels.

Gerry Turner rose to prominence as a septuagenarian star of a reality dating show. In an interview with People, he said he ...

A simple change to the chemotherapy regimen for people with Hodgkin lymphoma could reduce the long-term health impacts that ...

Primary non-Hodgkin's lymphoma of the breast (PBNHL) is uncommon. There have been only a few reports of breast lymphoma in the radiology literature. In this case report, we describe mammographic ...

A simple change to the chemotherapy regimen for people with Hodgkin lymphoma could reduce the long-term health impacts that ...

A minor modification to the chemotherapy regimen for Hodgkin lymphoma patients could lessen the long-term health effects of treatment, suggests a team of researchers in Cambridge. This discovery ...

When you learn about advances in cancer care and research, “you want to be part of it,” says frequent donor David Evans, who ...

Hodgkin's lymphoma (HL ... T-cell or B-cell skin lymphoma causes a rash along with itching and other characteristics, such as: Mycosis fungoides Mycosis fungoides is a T-cell lymphoma ...

Lymphoma is cancer of the lymphatic system, which causes swelling of the lymph nodes ... which are mainly categorized into two groups – Hodgkin's lymphoma and non-Hodgkin's lymphoma.